Arturo Chang-Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruiz, Consuelo Macías-Abraham, Laura Rodríguez-Noda, Carmen Valenzuela-Silva, . . . Vicente Verez-Bencomo. (2021). A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial. Elsevier.
Chicago Style (17th ed.) CitationArturo Chang-Monteagudo, et al. A Single Dose of SARS-CoV-2 FINLAY-FR-1A Vaccine Enhances Neutralization Response in COVID-19 Convalescents, with a Very Good Safety Profile: An Open-label Phase 1 Clinical Trial. Elsevier, 2021.
MLA (9th ed.) CitationArturo Chang-Monteagudo, et al. A Single Dose of SARS-CoV-2 FINLAY-FR-1A Vaccine Enhances Neutralization Response in COVID-19 Convalescents, with a Very Good Safety Profile: An Open-label Phase 1 Clinical Trial. Elsevier, 2021.